Using cisplatin-sensitive and cisplatin-resistant ovarian cancer cell models, Han et al. [20] detected that TET1 was significantly upregulated in cisplatin-resistant ovarian cancer cells compared with cisplatin-sensitive cells. This evidence concerns the gene TET1 and ovarian carcinoma.